Date : November 2024
The global medical devices reimbursement market size is projected to surpass around USD 1062.40 billion by 2032 from USD 535.9 billion in 2023, expanding at a solid CAGR of 7.90% between 2023 and 2033. The top companies in medical device reimbursement are UnitedHealth Group, Allianz, Nippon Life Insurance, Aviva, WellCare Health Plans, Aetna, BNP Paribas, Cigna, Humana, CVS Health, and Others.
| Report Attributes | Details |
| Market Size by 2032 | USD 1062.40 Billion |
| Market Size in 2023 | USD 535.90 Billion |
| Market Growth Rate from 2023 to 2032 | CAGR of 7.90% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Payer, Healthcare Setting, and Regions |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East, & Africa |
The medical devices reimbursement market is relatively fragmented, with a few large-scale worldwide firms and several small-scale regional competitors. They have long term contracts with medical care organizations around the world and are forming strategic alliances and collaborations with other companies in different countries to expand their business. The significant market innovations will also fuel the global industry’s growth. To strengthen their position in the medical devices reimbursement market, major firms use strategies such as collaborations, mergers, acquisitions, and the development of new products. To create technologically improved products, key market players are heavily spending in research and development activities.
We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344
